{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:45:53Z","timestamp":1790682353018,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bcp.2019.02.031","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T11:42:31Z","timestamp":1551267751000},"page":"134-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Micro-RNAs in inflammatory arthritis: From physiopathology to diagnosis, prognosis and therapeutic opportunities"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6008-503X","authenticated-orcid":false,"given":"Aur\u00e9lie","family":"Najm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Le Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2019.02.031_b0005","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2004.022137","article-title":"Combating the burden of musculoskeletal conditions","volume":"63","author":"Smolen","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.02.031_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","author":"Smolen","year":"2016","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.bcp.2019.02.031_b0015","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s12325-012-0037-5","article-title":"Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings","volume":"29","author":"Bonafede","year":"2012","journal-title":"Adv. Ther."},{"key":"10.1016\/j.bcp.2019.02.031_b0020","doi-asserted-by":"crossref","DOI":"10.1126\/science.1065329","article-title":"An extensive class of small RNAs in Caenorhabditis elegans","author":"Lee","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bcp.2019.02.031_b0025","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","article-title":"A microRNA polycistron as a potential human oncogene","volume":"435","author":"He","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2019.02.031_b0030","doi-asserted-by":"crossref","DOI":"10.1172\/JCI43897","article-title":"A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma","author":"Ory","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2019.02.031_b0035","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.10950","article-title":"miRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumors","author":"Jacques","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2019.02.031_b0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2019.02.031_b0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"Lanford","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bcp.2019.02.031_b0050","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1158\/1535-7163.MCT-14-0209","article-title":"Systemic delivery of a miR34a mimic as a potential therapeutic for liver cancer","volume":"13","author":"Daige","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2019.02.031_b0055","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/gutjnl-2014-307891","article-title":"MicroRNAs: new players in IBD","volume":"64","author":"Kalla","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2019.02.031_b0060","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/01616412.2016.1250857","article-title":"Identification of the miRNA\u2013mRNA regulatory network in multiple sclerosis","volume":"39","author":"Yang","year":"2017","journal-title":"Neurol. Res."},{"key":"10.1016\/j.bcp.2019.02.031_b0065","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/cmi.12159","article-title":"MicroRNAs and bacterial infection","volume":"15","author":"Staedel","year":"2013","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.bcp.2019.02.031_b0070","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.semarthrit.2017.01.003","article-title":"Epigenetic aspects of rheumatoid arthritis: contribution of non-coding RNAs","volume":"46","author":"Kolarz","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.02.031_b0075","doi-asserted-by":"crossref","first-page":"7305380","DOI":"10.1155\/2018\/7305380","article-title":"MicroRNA expression profiling in psoriatic arthritis","volume":"2018","author":"Pelosi","year":"2018","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bcp.2019.02.031_b0080","article-title":"The role of microRNAS in ankylosing spondylitis","volume":"95","author":"Li","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bcp.2019.02.031_b0085","doi-asserted-by":"crossref","first-page":"113543","DOI":"10.18632\/oncotarget.22708","article-title":"Differentially expressed mRNAs, lncRNAs, and miRNAs with associated co-expression and ceRNA networks in ankylosing spondylitis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2019.02.031_b0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fmed.2015.00064","article-title":"Insights into regulation of the miR-17-92 cluster of miRNAs in cancer","volume":"2","author":"Fuziwara","year":"2015","journal-title":"Front. Med."},{"issue":"188","key":"10.1016\/j.bcp.2019.02.031_b0095","first-page":"454","article-title":"TLR2 expression is regulated by microRNA miR-19 in rheumatoid fibroblast-like synoviocytes","volume":"1950","author":"Philippe","year":"2012","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.bcp.2019.02.031_b0100","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/annrheumdis-2012-201654","article-title":"MiR-20a regulates ASK1 expression and TLR4-dependent cytokine release in rheumatoid fibroblast-like synoviocytes","volume":"72","author":"Philippe","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.02.031_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00070","article-title":"The miR-17\u202f\u223c\u202f92 cluster: a key player in the control of inflammation during rheumatoid arthritis","volume":"4","author":"Philippe","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2019.02.031_b0110","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.4049\/jimmunol.1600360","article-title":"MicroRNA-17 suppresses TNF-\u03b1 signaling by interfering with TRAF2 and cIAP2 association in rheumatoid arthritis synovial fibroblasts","volume":"197","author":"Akhtar","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2019.02.031_b0115","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jbspin.2015.10.007","article-title":"MicroRNA-20a negatively regulates expression of NLRP3-inflammasome by targeting TXNIP in adjuvant-induced arthritis fibroblast-like synoviocytes","volume":"83","author":"Li","year":"2016","journal-title":"J. Bone Spine Rev. Rheum."},{"key":"10.1016\/j.bcp.2019.02.031_b0120","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.37834","article-title":"Tumor necrosis factor \u03b1-induced microRNA-18a activates rheumatoid arthritis synovial fibroblasts through a feedback loop in NF-\u03baB signaling: miR-18a enhances NF-\u03baB signaling in RASFs","volume":"65","author":"Trenkmann","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.02.031_b0125","first-page":"14562","article-title":"MiR-451 inhibits synovial fibroblasts proliferation and inflammatory cytokines secretion in rheumatoid arthritis through mediating p38MAPK signaling pathway","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bcp.2019.02.031_b0130","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.biopha.2017.07.042","article-title":"Elevated microRNA-125b promotes inflammation in rheumatoid arthritis by activation of NF-\u03baB pathway","volume":"93","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2019.02.031_b0135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2017.05.006","article-title":"MicroRNA-146a governs fibroblast activation and joint pathology in arthritis","volume":"82","author":"Saferding","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bcp.2019.02.031_b0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3892\/mmr.2015.4494","article-title":"Role of histone deacetylase 3 in ankylosing spondylitis via negative feedback loop with microRNA-130a and enhancement of tumor necrosis factor-1\u03b1 expression in peripheral blood mononuclear cells","volume":"13","author":"Jiang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bcp.2019.02.031_b0145","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nm.2050","article-title":"Synovial fibroblasts spread rheumatoid arthritis to unaffected joints","volume":"15","author":"Lef\u00e8vre","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2019.02.031_b0150","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00002281-200305000-00015","article-title":"Apoptosis in rheumatoid arthritis","volume":"15","author":"Baier","year":"2003","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bcp.2019.02.031_b0155","doi-asserted-by":"crossref","first-page":"74217","DOI":"10.18632\/oncotarget.12487","article-title":"MicroRNA-126 affects rheumatoid arthritis synovial fibroblast proliferation and apoptosis by targeting PIK3R2 and regulating PI3K-AKT signal pathway","volume":"7","author":"Qu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2019.02.031_b0160","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.yexmp.2015.12.015","article-title":"MicroRNA-126 targeting PIK3R2 promotes rheumatoid arthritis synovial fibro-blasts proliferation and resistance to apoptosis by regulating PI3K\/AKT pathway","volume":"100","author":"Gao","year":"2016","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bcp.2019.02.031_b0165","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3892\/mmr.2015.3642","article-title":"Downregulation of microRNA-221 decreases migration and invasion in fibroblast-like synoviocytes in rheumatoid arthritis","volume":"12","author":"Yang","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2019.02.031_b0170","doi-asserted-by":"crossref","first-page":"i88","DOI":"10.1136\/ard.2010.138669","article-title":"miR-124a as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis","volume":"70","author":"Kawano","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.02.031_b0175","first-page":"195","article-title":"MiR-338-5p suppresses rheumatoid arthritis synovial fibroblast proliferation and invasion by targeting ADAMTS-9","volume":"36","author":"Sun","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bcp.2019.02.031_b0180","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1159\/000493222","article-title":"miR-338-5p regulates the viability, proliferation, apoptosis and migration of rheumatoid arthritis fibroblast-like synoviocytes by targeting NFAT5","volume":"49","author":"Guo","year":"2018","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2019.02.031_b0185","first-page":"643","article-title":"miR-152 inhibits rheumatoid arthritis synovial fibroblast proliferation and induces apoptosis by targeting ADAM10","volume":"42","author":"Guo","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bcp.2019.02.031_b0190","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biopha.2017.09.120","article-title":"MicroRNA-29a inhibits proliferation and induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes by repressing STAT3","volume":"96","author":"Liu","year":"2017","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2019.02.031_b0195","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biopha.2017.09.079","article-title":"MiR-140-5p inhibits synovial fibroblasts proliferation and inflammatory cytokines secretion through targeting TLR4","volume":"96","author":"Li","year":"2017","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2019.02.031_b0200","first-page":"3312","article-title":"miR-137 decreases proliferation, migration and invasion in rheumatoid arthritis fibroblast-like synoviocytes","volume":"17","author":"Du","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bcp.2019.02.031_b0205","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.biopha.2017.01.063","article-title":"MiR-650 inhibits proliferation, migration and invasion of rheumatoid arthritis synovial fibroblasts by targeting AKT2","volume":"88","author":"Xu","year":"2017","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2019.02.031_b0210","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-015-0309-x","article-title":"MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt\/GSK-3\u03b2\/\u03b2-catenin pathway","volume":"10","author":"Sun","year":"2015","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.bcp.2019.02.031_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111266","article-title":"MiR-30a-3p negatively regulates BAFF synthesis in systemic sclerosis and rheumatoid arthritis fibroblasts","volume":"9","author":"Alsaleh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2019.02.031_b0220","first-page":"4953","article-title":"Expression and function of microRNA-188-5p in activated rheumatoid arthritis synovial fibroblasts","volume":"8","author":"Ruedel","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bcp.2019.02.031_b0225","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/art.34334","article-title":"Down-regulation of microRNA-34a* in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance","volume":"64","author":"Niederer","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.02.031_b0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11010-017-3003-3","article-title":"MicroRNA-192 suppresses cell proliferation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes by downregulating caveolin 1","volume":"432","author":"Li","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bcp.2019.02.031_b0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201851","article-title":"Small RNAs detected in exosomes derived from the MH7A synovial fibroblast cell line with TNF-\u03b1 stimulation","volume":"13","author":"Takamura","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2019.02.031_b0240","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/art.39694","article-title":"Monocyte microRNA expression in active systemic juvenile idiopathic arthritis implicates microRNA-125a-5p in polarized monocyte phenotypes","volume":"68","author":"Schulert","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bcp.2019.02.031_b0245","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molimm.2016.08.007","article-title":"MiR-146a modulates macrophage polarization in systemic juvenile idiopathic arthritis by targeting INHBA","volume":"77","author":"Li","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bcp.2019.02.031_b0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2017.01.002","article-title":"MicroRNA-155 contributes to enhanced resistance to apoptosis in monocytes from patients with rheumatoid arthritis","volume":"79","author":"Rajasekhar","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bcp.2019.02.031_b0255","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.cell.2010.02.021","article-title":"Th17 and regulatory T cells in mediating and restraining inflammation","volume":"140","author":"Littman","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2019.02.031_b0260","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00296-010-1710-0","article-title":"The Th17\/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis","volume":"32","author":"Wang","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bcp.2019.02.031_b0265","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bcp.2019.02.031_b0270","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/gene.2013.69","article-title":"Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs","volume":"15","author":"Smigielska-Czepiel","year":"2014","journal-title":"Genes Immun."},{"key":"10.1016\/j.bcp.2019.02.031_b0275","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/ard.2010.139857","article-title":"Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression","volume":"70","author":"Stagakis","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.02.031_b0280","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/rheumatology\/keu407","article-title":"SF Treg cells transcribing high levels of Bcl-2 and microRNA-21 demonstrate limited apoptosis in RA","volume":"54","author":"van der Geest","year":"2015","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.bcp.2019.02.031_b0285","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/jcmm.12353","article-title":"Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis","volume":"18","author":"Dong","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bcp.2019.02.031_b0290","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1136\/annrheumdis-2018-213511","article-title":"Maresin 1 improves the Treg\/Th17 imbalance in rheumatoid arthritis through miR-21","volume":"77","author":"Jin","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.02.031_b0295","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3389\/fimmu.2017.01932","article-title":"MicroRNA-155-at the critical interface of innate and adaptive immunity in arthritis","volume":"8","author":"Alivernini","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2019.02.031_b0300","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/art.30281","article-title":"Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice","volume":"63","author":"Bl\u00fcml","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.02.031_b0305","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/art.30321","article-title":"The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis","volume":"63","author":"Nakasa","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.02.031_b0310","doi-asserted-by":"crossref","unstructured":"Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritis, Ann. Rheum. Dis. (n.d.). https:\/\/ard.bmj.com\/content\/74\/6\/1265 (accessed December 20, 2018).","DOI":"10.1136\/annrheumdis-2013-204377"},{"key":"10.1016\/j.bcp.2019.02.031_b0315","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1089\/dna.2016.3349","article-title":"Upregulated expression of microRNA-16 correlates with Th17\/Treg cell imbalance in patients with rheumatoid arthritis","volume":"35","author":"Wu","year":"2016","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bcp.2019.02.031_b0320","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1159\/000494793","article-title":"Circulating exosomal miR-17 inhibits the induction of regulatory T cells via suppressing TGFBR II expression in rheumatoid arthritis","volume":"50","author":"Wang","year":"2018","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2019.02.031_b0325","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10753-016-0304-8","article-title":"Correlation between the expression of microRNA-301a-3p and the proportion of Th17 cells in patients with rheumatoid arthritis","volume":"39","author":"Tang","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.bcp.2019.02.031_b0330","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1002\/art.34550","article-title":"Brief report: amelioration of collagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA-223","volume":"64","author":"Li","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.02.031_b0335","first-page":"1058","article-title":"Over-expression of miR-223 in T-lymphocytes of early rheumatoid arthritis patients","volume":"29","author":"Sebastiani","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bcp.2019.02.031_b0340","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.humimm.2009.11.008","article-title":"miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis","volume":"71","author":"Fulci","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.bcp.2019.02.031_b0345","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/ni.1945","article-title":"The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes","volume":"11","author":"Stittrich","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2019.02.031_b0350","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/art.38291","article-title":"Review: the interleukin-23\/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond","volume":"66","author":"Smith","year":"2014","journal-title":"Arthritis Rheumatol. Hoboken NJ"},{"key":"10.1016\/j.bcp.2019.02.031_b0355","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/annrheumdis-2016-210175","article-title":"miR-10b-5p is a novel Th17 regulator present in Th17 cells from ankylosing spondylitis","volume":"76","author":"Chen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.02.031_b0360","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/cei.12089","article-title":"Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis","volume":"173","author":"Lai","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bcp.2019.02.031_b0365","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12970","article-title":"MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis","volume":"7","author":"Alivernini","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2019.02.031_b0370","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00018-017-2456-6","article-title":"Defective germinal center B-cell response and reduced arthritic pathology in microRNA-29a-deficient mice","volume":"74","author":"van Nieuwenhuijze","year":"2017","journal-title":"Cell. Mol. Life Sci. CMLS."},{"key":"10.1016\/j.bcp.2019.02.031_b0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069118","article-title":"Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis","volume":"8","author":"Murata","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2019.02.031_b0380","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/342524","article-title":"Circulating miRNA-125b is a potential biomarker predicting response to rituximab in rheumatoid arthritis","volume":"2014","author":"Duroux-Richard","year":"2014","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bcp.2019.02.031_b0385","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/annrheumdis-2011-200803","article-title":"Identification of microRNA-221\/222 and microRNA-323-3p association with rheumatoid arthritis via predictions using the human tumour necrosis factor transgenic mouse model","volume":"71","author":"Pandis","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.02.031_b0390","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00296-013-2767-3","article-title":"MicroRNA-323-3p: a new biomarker and potential therapeutic target for rheumatoid arthritis","volume":"34","author":"Xu","year":"2014","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bcp.2019.02.031_b0395","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1459-x","article-title":"Whole blood microRNA expression pattern differentiates patients with rheumatoid arthritis, their seropositive first-degree relatives, and healthy unrelated control subjects","volume":"19","author":"Anaparti","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcp.2019.02.031_b0400","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1136\/annrheumdis-2012-202815","article-title":"Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis","volume":"73","author":"Filkov\u00e1","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.02.031_b0405","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13075-015-0555-z","article-title":"Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNF\u03b1","volume":"17","author":"Castro-Villegas","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bcp.2019.02.031_b0410","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.intimp.2018.07.028","article-title":"Analysis of miRNA expression in patients with rheumatoid arthritis during remission and relapse after a 5-year trial of tofacitinib treatment","volume":"63","author":"Fern\u00e1ndez-Ruiz","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2019.02.031_b0415","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/tpj.2015.30","article-title":"Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis","volume":"16","author":"Krintel","year":"2016","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.bcp.2019.02.031_b0420","article-title":"Circulating miR-10a as predictor of therapy response in rheumatoid arthritis patients treated with methotrexate","author":"Hong","year":"2017","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bcp.2019.02.031_b0425","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/14397595.2013.854077","article-title":"Elevated miR-29a expression is not correlated with disease activity index in PBMCs of patients with ankylosing spondylitis","volume":"24","author":"Huang","year":"2014","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.bcp.2019.02.031_b0430","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/504208","article-title":"Disorders of microRNAs in peripheral blood mononuclear cells: as novel biomarkers of ankylosing spondylitis and provocative therapeutic targets","volume":"2015","author":"Lv","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bcp.2019.02.031_b0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185323","article-title":"Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis","volume":"12","author":"Prajzlerov\u00e1","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2019.02.031_b0440","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s10067-018-4017-2","article-title":"Predictive value of microRNA-132 and its target gene NAG-1 in evaluating therapeutic efficacy of non-steroidal anti-inflammatory drugs treatment in patients with ankylosing spondylitis","volume":"37","author":"Guo","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.bcp.2019.02.031_b0445","first-page":"113","article-title":"Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis","volume":"35","author":"Ciancio","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bcp.2019.02.031_b0450","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3899\/jrheum.150593","article-title":"Plasma miR-26a as a diagnostic biomarker regulates cytokine expression in systemic juvenile idiopathic arthritis","volume":"43","author":"Sun","year":"2016","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bcp.2019.02.031_b0455","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s10067-015-2922-1","article-title":"Serum microRNAs as potential biomarkers of juvenile idiopathic arthritis","volume":"34","author":"Kamiya","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.bcp.2019.02.031_b0460","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/rheumatology\/kex233","article-title":"Downregulation of miR-106b attenuates inflammatory responses and joint damage in collagen-induced arthritis","volume":"56","author":"Tao","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.bcp.2019.02.031_b0465","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.7150\/thno.29313","article-title":"Delivery of miR-146a to Ly6Chigh monocytes inhibits pathogenic bone erosion in inflammatory arthritis","volume":"8","author":"Ammari","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2019.02.031_b0470","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/art.39446","article-title":"Amelioration of experimental autoimmune arthritis through targeting of synovial fibroblasts by intraarticular delivery of microRNAs 140\u20133p and 140\u20135p: delivery of miR140-3p and miR140-5p to treat autoimmune arthritis","volume":"68","author":"Peng","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bcp.2019.02.031_b0475","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.24762","article-title":"Induction of apoptosis in the synovium of mice with autoantibody-mediated arthritis by the intraarticular injection of double-stranded microRNA-15a","volume":"60","author":"Nagata","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2019.02.031_b0480","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/annrheumdis-2014-206417","article-title":"MicroRNA-124 inhibits the progression of adjuvant-induced arthritis in rats","volume":"75","author":"Nakamachi","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.02.031_b0485","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2019.02.031_b0490","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of duchenne muscular dystrophy: eteplirsen for DMD","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2019.02.031_b0495","first-page":"119","article-title":"Mipomersen (Kynamro)","volume":"39","author":"Wong","year":"2014","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.bcp.2019.02.031_b0500","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1083\/jcb.201208082","article-title":"Discovering the first microRNA-targeted drug","volume":"199","author":"Lindow","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2019.02.031_b0505","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.omtn.2017.06.005","article-title":"Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.bcp.2019.02.031_b0510","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.4049\/jimmunol.1403146","article-title":"Prospects for therapeutic targeting of microRNAs in human immunological diseases","volume":"194","author":"Luck","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2019.02.031_b0515","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/molecules23071500","article-title":"MicroRNA-regulated gene delivery systems for research and therapeutic purposes","volume":"23","author":"Dhungel","year":"2018","journal-title":"Molecules"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219300796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219300796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:04:30Z","timestamp":1757768670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219300796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":103,"alternative-id":["S0006295219300796"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.02.031","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Micro-RNAs in inflammatory arthritis: From physiopathology to diagnosis, prognosis and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}